Acute myocardial infarction mortality related to use of calcium antagonists before admission to hospital

Cardiovascular Drugs and Therapy

Volumn 12, Issue 2, 1998, Pages 183-187

  Landmark, K ^a   Reikvam, A ^b   Abdelnoor, M ^b   Sivertssen, E ^b   Aursnes, I ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Calcium antagonists; Coronary mortality; Hospital mortality; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; NITRIC ACID DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; AGED; ANAMNESIS; ARTICLE; DIABETES MELLITUS; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 0031747020     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007783227823     Document Type: Article

References (30)

1. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: An overview. Br Med J 1989;299:1187-1192.
2. Muller JE, Morrison J, Stone PH, et al. Nifedipine therapy for patients with threatened and acute myocardial infarction: A randomized, double-blind, placebo-controlled comparison. Circulation 1984;69:740-747.
3. Sirnes PA, Overskeid K, Pedersen TR, et al. Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: The Norwegian Nifedipine Multicenter Trial. Circulation 1984;70:638-644.
4. Erbel R, Pop T, Meinertz T, et al. Combination of calcium channel blocker and thrombolytic therapy in acute myocardial infarction. Am Heart J 1988;115:529-538.
5. Wilcox RG, Hampton JR, Banks DC, et al. Trial of early nifedipine in acute myocardial infarction: The Trent study. Br Med J 1986;293:1204-1208.
6. Walker LJE, MacKenzie G, Adgey AAJ. Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction. Br Heart J 1988;59:403-411.
7. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
8. Welman E, Caroll BJ, Lawson JS, Selwyn AP, Fox KM. Effects of nifedipine on creatine kinase release during myocardial ischemia in dogs. Eur J Cardiol 1978;7:379-389.
9. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after myocardial infarction (The Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 1990;55:779-785.
10. Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. N Engl J Med 1986;315:423-429.
11. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319: 385-392.
12. Landmark K, Abdelnoor M, Kilhovd B, Dorum H-P. Infarct size as estimated from peak creatine kinase and lactate dehydrogenase is probably reduced in patients using calcium antagonists at the onset of symptoms. Cardiovasc Drugs Ther 1997;11:557-565.
13. European Secondary Prevention Study Group. Translation of clinical trials into practice: A European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 1996;347:1203-1207.
14. Kleinbaum D, Kupper L, Morgenstern H. Epidemiologic Research. New York: Van Nostrand Reinhold, 1982.
15. Rumeau-Rouquette C, Bréart G, Padieu R. Méthodes en Épidémiologie. Paris; Médecine-Sciences Flammarion, 1989.
16. Hennekens C, Buring J, Mayrent S. Epidemiology in Medicine. Boston: Little Brown, 1987.
17. Hosmer DW, Jr., Lemeskow S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
18. Braun S, Boyko V, Behar S, et al. Calcium antogonists and mortality in patients with coronary artery disease: A cohort study of 11,575 patients. J Am Coll Cardiol 1996;28:7-11.
19. Leader SG, Mallick R, Briggs NC. Myocardial infarction in newly diagnosed hypertensives Medicaid patients free of coronary heart disease and treated with calcium channel blockers. Am J Med 1997;120:150-157.
20. Boden WE, Fischer Hansen J, Lau J, Roberts R. Benefical effect of heart rate-lowering calcium channel blockers (diltiazem, verapamil) on reducing long-term (12-18 months) cardiac death and nonfatal reinfarctions in patients recovering from acute non-Q-wave myocardial infarction. Circulation 1995;92(Suppl. I):I81.
21. Andersen LT, Sigurd B, Fischer Hansen J. Verapamil and circadian variation of sudden cardiac death. Am Heart J 1996;131:409-410.
22. Rengo F, Carbonin P, Pahor M, et al. A controlled trial of verapamil in patients after acute myocardial infarction: Results of the Calcium Antagonist Reinfarction Italian Study (CRIS). Am J Cardiol 1996;77:365-369.
23. Opie LH, Messerli FH. Nifedipine and mortality. Grave defects in the dossier. Circulation 1995;92:1068-1073.
24. Hosie J, Bremner AD, Fell PJ, James IGV, Saul PA, Taylor SH. Side effects of dihydropyridine therapy: Comparison of amlodipine and nifedipine retard. J Cardiovasc Pharmacol 1993;22 (Suppl. A):S9-S12.
25. Alderman MH, Cohen H, Roqué R, Madhavan S. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 1997; 349:594-598.
26. Abascal VM, Larson MG, Evans JC, Poli KA et al. Calcium channel blockers (CCB) use is not associated with increased mortality (abstr). Circulation 1996;94:I578.
27. Seitelberger R, Zwölfer W, Huber S, et al. Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronary bypass grafting. Circulation 1991;83:460-468.
28. Sheiban I, Tonni S, Chizzoni A, Marini A, Trevi G. Recovery of left ventricular function following early reperfusion in acute myocardial infarction: A potential role for the calcium antagonist nisoldepine. Cardiovasc Drugs Ther 1997;11: 5-16.
29. Gong L, Zhang W, Zhu Y, et al. Shanghai Trial Of Nifedipine in the Elderly (STONE). J Hypertens 1996;14:1237-1245.
30. Staessen JA, Fagard R, Lutgarde T, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-764.